- Home
- GCDT vs INKT Comparison
GCDT vs INKT Comparison
Compare GCDT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.65
N/A
Current Price
$10.53
Company Overview
Basic Information| Metric | GCDT | INKT |
|---|---|---|
| Founded | 1992 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 57.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GCDT | INKT |
|---|---|---|
| Price | $2.65 | $10.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 28.4K | 4.6K |
| Earning Date | 01-01-0001 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.80 | $6.66 |
| 52 Week High | $5.32 | $76.00 |
Technical Indicators
Market Signals| Indicator | GCDT | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 34.49 | 35.24 |
| Support Level | $1.80 | $6.85 |
| Resistance Level | $3.75 | $12.78 |
| Average True Range (ATR) | 0.43 | 0.36 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 32.30 | 11.27 |
Price Performance
Historical Comparison GCDT
INKT
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.